A relevant communication between lipid metabolism and signaling has been described in GBM involving EGFR, glucose and the transcriptional regulator of de novo lipogenesis so‐called sterol regulatory element‐binding protein‐1 (SREBP1). The gene discussed is EGFR; the disease is glioblastoma.